Free Trial
$100 Off Ends Tonight! MarketBeat All Access Returns to $249
  • 0Days
  • 0Hours
  • 0Minutes
  • 0Seconds
Save $100 Now
Claim MarketBeat All Access Sale Promotion

Fairmount Funds Management LLC Top Holdings and 13F Report (2021)

About Fairmount Funds Management LLC

Investment Activity

  • Fairmount Funds Management LLC has $1.38 billion in total holdings as of September 30, 2021.
  • Fairmount Funds Management LLC owns shares of 12 different stocks, but just 6 companies or ETFs make up 80% of its holdings.
  • Approximately 18.94% of the portfolio was purchased this quarter.
  • About 34.85% of the portfolio was sold this quarter.
  • This quarter, Fairmount Funds Management LLC has purchased 13 new stocks and bought additional shares in 2 stocks.
  • Fairmount Funds Management LLC sold shares of 3 stocks and completely divested from 2 stocks this quarter.

Largest Holdings

DAMORA THERAPEUTICS INC
$225,666,700
DIANTHUS THERAPEUTICS INC
$212,921,069
Cogent Biosciences
$211,826,559
SPYRE THERAPEUTICS INC
$202,673,014
ORUKA THERAPEUTICS INC
$181,743,101

Largest New Holdings this Quarter

36322Q206 - DAMORA THERAPEUTICS INC
$225,666,700 Holding

Largest Purchases this Quarter

DAMORA THERAPEUTICS INC
8,713,000 shares (about $225.67M)
DIANTHUS THERAPEUTICS INC
400,000 shares (about $33.57M)
ZENAS BIOPHARMA INC
150,000 shares (about $2.93M)

Largest Sales this Quarter

APOGEE THERAPEUTICS INC
1,750,000 shares (about $147.30M)
Cogent Biosciences
3,500,000 shares (about $134.72M)
Enliven Therapeutics
1,855,800 shares (about $72.75M)

Sector Allocation Over Time

Map of 500 Largest Holdings ofFairmount Funds Management LLC

 
 
Selling
 
 
Neutral
 
 
Buying
Issuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSector
DAMORA THERAPEUTICS INC
$225,666,700$225,666,700 â–²New Holding8,713,00016.3%COM NEW
DIANTHUS THERAPEUTICS INC
$212,921,069$33,568,000 â–²18.7%2,537,19115.4%COM
Cogent Biosciences, Inc. stock logo
COGT
Cogent Biosciences
$211,826,559$134,715,000 â–¼-38.9%5,503,41815.3%Medical
SPYRE THERAPEUTICS INC
$202,673,0140.0%4,018,10114.6%COM NEW
ORUKA THERAPEUTICS INC
$181,743,1010.0%3,705,26213.1%COM
Viridian Therapeutics, Inc. stock logo
VRDN
Viridian Therapeutics
$76,566,7980.0%3,914,4585.5%Medical
Enliven Therapeutics, Inc. stock logo
ELVN
Enliven Therapeutics
$72,741,245$72,747,360 â–¼-50.0%1,855,6445.3%Medical
JADE BIOSCIENCES INC
$63,976,5910.0%4,553,4944.6%COM NEW
CRESCENT BIOPHARMA INC.
$50,478,2980.0%2,747,8663.6%COM
ZENAS BIOPHARMA INC
$46,118,939$2,932,500 â–²6.8%2,359,0253.3%COM
APOGEE THERAPEUTICS INC
$25,137,118$147,297,500 â–¼-85.4%298,6471.8%COM
INHIBIKASE THERAPEUTICS INC
$14,490,0000.0%8,625,0001.0%COM NEW
Nuvalent, Inc. stock logo
NUVL
Nuvalent
$0$73,185,562 â–¼-100.0%00.0%Medical
KINIKSA PHARMACEUTICALS INTL
$0$54,437,130 â–¼-100.0%00.0%ORD SHS CL A

Showing largest 100 holdings. View all holdings.
SEC Filings and Trading Data